What does Procept BioRobotics do?

PROCEPT BioRobotics Corporation is a surgical robotics company dedicated to improving patient care through innovative solutions in urology. The company is publicly traded on NASDAQ under the ticker symbol PRCT. Its mission focuses on transforming the treatment of benign prostatic hyperplasia (BPH) by collaborating with urologists to provide advanced robotic solutions that enhance patient outcomes. The company develops and sells sophisticated robotic surgical systems for minimally invasive urologic procedures. Key products include the AquaBeam Robotic System, an image-guided system for BPH treatment, and the HYDROS Robotic System, an AI-powered platform for Aquablation therapy. Aquablation therapy is a unique ultrasound-guided, robotic-assisted waterjet treatment that effectively addresses BPH while preserving sexual function and continence. PROCEPT BioRobotics emphasizes precision in surgical outcomes through computer-assisted treatment planning, ensuring optimal tissue resection. The company primarily generates revenue in the United States and has a presence in international markets.